IMMUNE PHARMACEUTICALS INC's ticker is IMNP and the CUSIP is 45254C101. A total of 14 filers reported holding IMMUNE PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2017 | $5,000 | -28.6% | 35,767 | -1.3% | 0.00% | – |
Q4 2016 | $7,000 | -84.1% | 36,225 | -76.9% | 0.00% | – |
Q3 2016 | $44,000 | +76.0% | 156,868 | +363.6% | 0.00% | – |
Q4 2015 | $25,000 | -28.6% | 33,837 | +13.4% | 0.00% | – |
Q3 2015 | $35,000 | -36.4% | 29,848 | +5.0% | 0.00% | – |
Q2 2015 | $55,000 | -8.3% | 28,422 | -15.5% | 0.00% | – |
Q1 2015 | $60,000 | -3.2% | 33,616 | +2.7% | 0.00% | – |
Q4 2014 | $62,000 | -41.0% | 32,745 | +5.1% | 0.00% | – |
Q3 2014 | $105,000 | – | 31,143 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Geduld E E | 35,000 | $68,000 | 0.04% |
Bank Pictet & Cie (Europe) AG | 12,900 | $25,000 | 0.02% |
Ifrah Financial Services, Inc. | 21,956 | $42,000 | 0.02% |
Pine River Capital Management L.P. | 250,000 | $295,000 | 0.00% |
LADENBURG THALMANN FINANCIAL SERVICES INC. | 1,000 | $2,000 | 0.00% |
BlackRock Investment Management, LLC | 3,245 | $6,000 | 0.00% |
CITIGROUP INC | 79 | $0 | 0.00% |
GOLDMAN SACHS GROUP INC | 28,422 | $55,000 | 0.00% |
MORGAN STANLEY | 41 | $0 | 0.00% |
BlackRock Institutional Trust Company, N.A. | 3,930 | $8,000 | 0.00% |